Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens

Scherrer, Alexandra U; Böni, Jürg; Yerly Ferrillo, Sabine; Klimkait, Thomas; Aubert, Vincent; Fürrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F

doi:10.1371/journal.pone.0050307

Scientific article

English

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens

ContributorsScherrer, Alexandra U; Böni, Jürg; Yerly Ferrillo, Sabine; Klimkait, Thomas; Aubert, Vincent; Fürrer, Hansjakob; Calmy, Alexandra

; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F

Published inPloS one, vol. 7, no. 11, e50307

Publication date2012

Abstract

The accumulation of mutations after long-lasting exposure to a failing combination antiretroviral therapy (cART) is problematic and severely reduces the options for further successful treatments.

Keywords

Adult
Anti-HIV Agents/administration & dosage/therapeutic use
Antiretroviral Therapy, Highly Active
Cohort Studies
Drug Resistance, Viral/genetics
Female
Genotype
HIV Infections/drug therapy/virology
HIV-1/drug effects/genetics
Humans
Male
Middle Aged
Mutation
Protease Inhibitors/administration & dosage/therapeutic use
Reverse Transcriptase Inhibitors/administration & dosage/therapeutic use
Risk Factors
Time Factors
Treatment Failure
Viral Load

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

VIH/SIDA (930)

Citation (ISO format)

SCHERRER, Alexandra U et al. Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. In: PloS one, 2012, vol. 7, n° 11, p. e50307. doi: 10.1371/journal.pone.0050307

Article (Published version)

CC BY

Identifiers

PID : unige:31599
DOI : 10.1371/journal.pone.0050307
PMID : 23189194

Journal ISSN1932-6203

646views

285downloads

Creation03/12/2013 11:29:00

First validation03/12/2013 11:29:00

Update14/03/2023 20:39:51

Status update14/03/2023 20:39:51

Last indexation30/10/2024 15:09:25

Archive ouverte UNIGE

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens

The accumulation of mutations after long-lasting exposure to a failing combination antiretroviral therapy (cART) is problematic and severely reduces the options for further successful treatments.

Technical informations